Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine

AAPS PharmSciTech

Volumn 12, Issue 3, 2011, Pages 1011-1018

  Li, Su ^a   Ji, Zhaoshuai ^a   Zou, Meijuan ^a   Nie, Xin ^a   Shi, Yijie ^a   Cheng, Gang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

characterization; pharmacokinetics; preparation; solid lipid nanoparticles; tetrandrine

Indexed keywords

DEOXYCHOLATE SODIUM; GLYCEROL PALMITOSTEARATE; SOLID LIPID NANOPARTICLE; STEARIC ACID; TETRANDRINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG SYNTHESIS; DRUG UPTAKE; EMULSION; MALE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; TISSUE DISTRIBUTION; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZYLISOQUINOLINES; CALORIMETRY, DIFFERENTIAL SCANNING; DEOXYCHOLIC ACID; DIGLYCERIDES; EMULSIFYING AGENTS; EXCIPIENTS; GLYCERIDES; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; LIPIDS; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLOXAMER; RATS; RATS, WISTAR; SOLUBILITY; STEARIC ACIDS; TISSUE DISTRIBUTION; ULTRASONICS;

EID: 80052607638     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9665-3     Document Type: Article

References (38)

1. K Jores W Mehnert M Drechsler H Bunjes C Johann K Mäder 2004 Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy J Control Release 95 2 217 227 14980770 10.1016/j.jconrel.2003.11.012 1:CAS:528: DC%2BD2cXhsVCmsrw%3D (Pubitemid 38230037)
2. RH Müller CM Keck 2004 Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles J Biochem 113 1-3 151 170 (Pubitemid 39237077)
3. RH Müller K Mader S Gohla 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur J Pharm Biopharm 50 1 161 177 10840199 10.1016/S0939-6411(00)00087-4 (Pubitemid 30326695)
4. C Schwarz WJ Mehnert S Lucks RH Müller 1994 Solid lipid nanoparticles(SLN) for controlled drug delivery. I. Production, characterization and sterilization J Control Release 30 83 96 10.1016/0168-3659(94)90047-7 1:CAS:528:DyaK2cXktFOqsLo%3D (Pubitemid 24173181)
5. C Freitas RH Müller 1998 Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN(TM)) dispersions Int J Pharm 168 2 221 229 10.1016/S0378-5173(98)00092-1 1:CAS:528:DyaK1cXksF2ls7o%3D (Pubitemid 28349963)
6. W Mehnert K Mäder 2001 Solid lipid nanoparticles: production, characterization and applications Adv Drug Delivery Rev 47 2-3 165 196 10.1016/S0169-409X(01)00105-3 1:CAS:528:DC%2BD3MXislGls7g%3D (Pubitemid 32324113)
7. C Olbrich RH Müller 1999 Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures Int J Pharm 180 1 31 39 10089289 10.1016/S0378-5173(98)00404-9 1:CAS:528:DyaK1MXhvFCru7k%3D (Pubitemid 29131440)
8. Marengo E, Cavalli R, Caputo O, Rodriguez L, Gasco MR. Scale-up of the preparation process of solid lipid nanospheres. Part I. Int J Pharm. 205;3(1-2).
9. LW Fu YM Zhang YJ Liang XP Yang QC Pan 2002 The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells Eur J Cancer 38 3 418 426 11818209 10.1016/S0959-8049(01)00356-2 1:CAS:528:DC%2BD38XovFSgsg%3D%3D (Pubitemid 34121971)
10. 2+ channels in vascular endothelial cells Life Sci 68 7 841 847 11205874 10.1016/S0024-3205(00)00988-7 1:CAS:528:DC%2BD3MXkvVWhtQ%3D%3D (Pubitemid 32168013)
11. B Liu T Wang X Qian G Liu L Yu Y Ding 2008 Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids Cancer Letters 268 1 166 175 18495333 10.1016/j.canlet.2008.03.059 1:CAS:528:DC%2BD1cXpt1Grsrg%3D
12. + channels Life Sci 56 5 295 306 10.1016/0024-3205(94)00952-X 1:CAS:528:DyaK2MXivFOitbk%3D (Pubitemid 124014538)
13. J-M Wu Y Chen J-C Chen T-Y Lin S-H Tseng 2010 Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice Cancer Letters 287 2 187 195 19586712 10.1016/j.canlet.2009.06.009 1:CAS:528:DC%2BC3cXosVKk
14. Y Li L Dong A Jia X Chang H Xue 2006 Preparation and characterization of solid lipid nanoparticles loaded traditional chinese medicine Int J Biol Macromol 38 3-5 296 299 16600362 10.1016/j.ijbiomac.2006.03.006 1:CAS:528:DC%2BD28XkvVyhsr0%3D
15. DW Fry JC White ID Goldman 1978 Rapid separation of low molecular weight solutes from liposomes without dilution Anal Biochem 90 2 809 815 727510 10.1016/0003-2697(78)90172-0 1:CAS:528:DyaE1MXjsFOlsQ%3D%3D (Pubitemid 9087732)
16. F Han S Li R Yin X Shi Q Jia 2008 Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen Drug Dev Ind Pharm 34 453 458 18401788 10.1080/03639040701833708 1:CAS:528:DC%2BD1cXksVaiu74%3D (Pubitemid 351519673)
17. R Cavalli O Caputo ME Carlotti M Trotta C Scarnecchia MR Gasco 1997 Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles Int J Pharm 148 1 47 54 10.1016/S0378-5173(96)04822-3 1:CAS:528:DyaK2sXivVyjsLs%3D (Pubitemid 27152216)
18. L Hu Q Xing J Meng C Shang 2010 Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles AAPS PharmSciTech 11 2 582 587 20352534 10.1208/s12249-010-9410-3
19. L Battaglia M Gallarate R Cavalli M Trotta 2010 Solid lipid nanoparticles produced through a coacervation method J Microencapsul 27 1 78 85 19538034 10.3109/02652040903031279 1:CAS:528:DC%2BC3cXmvVyksA%3D%3D
20. E Gonzalez-Mira MA Egea ML Garcia EB Souto 2010 Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC Colloids Surf B 81 2 412 421 10.1016/j.colsurfb.2010.07.029 1:CAS:528:DC%2BC3cXhtFynsLnF
21. H Chen X Chang D Du J Li H Xu X Yang 2006 Microemulsion-based hydrogel formulation of ibuprofen for topical delivery Int J Pharm 315 1-2 52 58 16600540 10.1016/j.ijpharm.2006.02.015 1:CAS:528:DC%2BD28XksFyhsL4%3D (Pubitemid 43674110)
22. M Patel R Patel J Parikh A Solanki B Patel 2009 Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole AAPS PharmSciTech 10 3 917 923 19609836 10.1208/s12249-009-9286-2 1:CAS:528:DC%2BC3cXosVantr4%3D
23. MA Casadei F Cerreto S Cesa M Giannuzzo M Feeney C Marianecci, et al. 2006 Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations Int J Pharm 325 1-2 140 146 16846705 10.1016/j.ijpharm.2006.06.012 1:CAS:528:DC%2BD28XhtFSgsrrP (Pubitemid 44573689)
24. F Li Y Wang Z Liu X Lin H He X Tang 2010 Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers Drug Dev Ind Pharm. 36 5 508 517 19821716 10.3109/03639040903264397 1:CAS:528:DC%2BC3cXmtVGjsbo%3D
25. M Bhalekar V Pokharkar A Madgulkar N Patil N Patil 2009 Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery AAPS PharmSciTech 10 1 289 296 19294517 10.1208/s12249-009-9199-0 1:CAS:528:DC%2BC3cXotV2mu78%3D
26. Z Cui RJ Mumper 2002 Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses J Pharm Pharmacol 54 1195 1203 12356273 10.1211/002235702320402035 1:CAS:528:DC%2BD38XotVGgsrY%3D
27. EB Souto RH Müller 2006 The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents Pharmazie 61 431 437 16724541 1:CAS:528:DC%2BD28XksV2gsLk%3D (Pubitemid 43724420)
28. G Reich 1997 In vitro stability of poly (d, l-lactide) and poly (d, l-lactide)/poloxamer nanoparticles in gastrointestinal fluids Drug Dev Ind Pharm. 23 1191 1198 10.3109/03639049709146156 1:CAS:528:DyaK1cXitFCn
29. EB Souto RH Müller 2006 Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization J Microencapsul 23 377 388 16854814 10.1080/02652040500435295 1:CAS:528:DC%2BD28XovVOqsbs%3D (Pubitemid 44132547)
30. J Liu T Gong C Wang Z Zhong Z Zhang 2007 Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization Int J Pharm 340 1-2 153 162 17428627 10.1016/j.ijpharm.2007.03.009 1:CAS:528:DC%2BD2sXns1Kgs7o%3D (Pubitemid 47044961)
31. P Shahgaldian J Gualbert K Aïssa AW Coleman 2003 A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles Eur J Pharm Biopharm 55 2 181 184 12637094 10.1016/S0939-6411(02)00196-0 1:CAS:528:DC%2BD3sXhvFaju7s%3D (Pubitemid 36299215)
32. SC Yang JB Zhu 2002 Preparation and characterization of camptothecin solid lipid nanoparticles Drug Dev Ind Pharm 28 265 274 12026219 10.1081/DDC-120002842 1:CAS:528:DC%2BD38XjslSitbw%3D (Pubitemid 34475673)
33. V Venkateswarlu K Manjunath 2004 Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J Control Release 95 3 627 638 15023472 10.1016/j.jconrel.2004.01.005 1:CAS:528: DC%2BD2cXitVKgtLw%3D (Pubitemid 38344153)
34. W-L Zhang X Gu H Bai R-H Yang C-D Dong J-P Liu 2010 Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug Int J Pharm 391 1-2 313 321 20214958 10.1016/j.ijpharm.2010.03.011 1:CAS:528:DC%2BC3cXltFCntr8%3D
35. P Vaupel F Kallinowski P Okunieff 1989 Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Research 49 23 6449 2684393 1:CAS:528:DyaK3cXltlSmtQ%3D%3D
36. F Li Y Weng L Wang H He J Yang X Tang 2010 The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers Int J Pharm 393 1-2 204 212 10.1016/j.ijpharm.2010.04.005
37. K Manjunath V Venkateswarlu 2005 Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration J Control Release 107 2 215 228 16014318 10.1016/j.jconrel.2005.06.006 1:CAS:528:DC%2BD2MXhtVShtr7I (Pubitemid 41319672)
38. Y Mizushima T Hamano K Yokoyama 1982 Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion Ann Rheum Dis 41 3 263 267 6896429 10.1136/ard.41.3.263 1:CAS:528: DyaL38XlsFKks7s%3D (Pubitemid 12087764)